BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30503841)

  • 21. Cebranopadol: a novel potent analgesic nociceptin/orphanin FQ peptide and opioid receptor agonist.
    Linz K; Christoph T; Tzschentke TM; Koch T; Schiene K; Gautrois M; Schröder W; Kögel BY; Beier H; Englberger W; Schunk S; De Vry J; Jahnel U; Frosch S
    J Pharmacol Exp Ther; 2014 Jun; 349(3):535-48. PubMed ID: 24713140
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to morphine analgesic tolerance in rats with deleted transient receptor potential vanilloid type 1-expressing sensory neurons.
    Chen SR; Prunean A; Pan HM; Welker KL; Pan HL
    Neuroscience; 2007 Mar; 145(2):676-85. PubMed ID: 17239544
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Gupta SK; Gohil D; Momin MB; Yadav S; Chichra A; Punatar S; Gokarn A; Mirgh S; Jindal N; Nayak L; Hingorani L; Khattry N; Gota V
    Cell Transplant; 2024; 33():9636897241226573. PubMed ID: 38258793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analgesia, enhancement of spinal morphine antinociception, and inhibition of tolerance by ultra-low dose of the α2A-adrenoceptor selective antagonist BRL44408.
    Milne B; Jhamandas K; Sutak M; Grenier P; Cahill CM
    Eur J Pharmacol; 2014 Nov; 743():89-97. PubMed ID: 25242119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrathecal atipamezole augments the antinociceptive effect of morphine in rats.
    Lilius TO; Rauhala PV; Kambur O; Rossi SM; Väänänen AJ; Kalso EA
    Anesth Analg; 2012 Jun; 114(6):1353-8. PubMed ID: 22556211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain.
    Rashid MH; Inoue M; Toda K; Ueda H
    J Pharmacol Exp Ther; 2004 Apr; 309(1):380-7. PubMed ID: 14718584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-nociceptive and anti-inflammatory effects of Withania somnifera root in fructose fed male rats.
    Shahraki MR; Samadi Noshahr Z; Ahmadvand H; Nakhaie A
    J Basic Clin Physiol Pharmacol; 2016 Jun; 27(4):387-91. PubMed ID: 27383871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinociceptive effects of the 6-O-sulfate ester of morphine in normal and diabetic rats: Comparative role of mu- and delta-opioid receptors.
    Yadlapalli JSK; Ford BM; Ketkar A; Wan A; Penthala NR; Eoff RL; Prather PL; Dobretsov M; Crooks PA
    Pharmacol Res; 2016 Nov; 113(Pt A):335-347. PubMed ID: 27637375
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological evidence for systemic and peripheral antinociceptive activities of pioglitazone in the rat formalin test: Role of PPARγ and nitric oxide.
    Mansouri MT; Naghizadeh B; Ghorbanzadeh B; Rajabi H; Pashmforoush M
    Eur J Pharmacol; 2017 Jun; 805():84-92. PubMed ID: 28286124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent bullatine A enhances morphine antinociception and inhibits morphine antinociceptive tolerance by indirect activation of spinal κ-opioid receptors.
    Huang Q; Sun ML; Chen Y; Li XY; Wang YX
    J Ethnopharmacol; 2017 Jan; 196():151-159. PubMed ID: 27989510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
    Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
    Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihyperalgesic effects of ashwagandha (Withania somnifera root extract) in rat models of postoperative and neuropathic pain.
    Lim DW; Kim JG; Lim EY; Kim YT
    Inflammopharmacology; 2018 Feb; 26(1):207-215. PubMed ID: 28849547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MGM-9 [(E)-methyl 2-(3-ethyl-7a,12a-(epoxyethanoxy)-9-fluoro-1,2,3,4,6,7,12,12b-octahydro-8-methoxyindolo[2,3-a]quinolizin-2-yl)-3-methoxyacrylate], a derivative of the indole alkaloid mitragynine: a novel dual-acting mu- and kappa-opioid agonist with potent antinociceptive and weak rewarding effects in mice.
    Matsumoto K; Takayama H; Narita M; Nakamura A; Suzuki M; Suzuki T; Murayama T; Wongseripipatana S; Misawa K; Kitajima M; Tashima K; Horie S
    Neuropharmacology; 2008 Aug; 55(2):154-65. PubMed ID: 18550129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of sex and relative efficacy at the mu opioid receptor in the development of tolerance and cross-tolerance to the antinociceptive effects of opioids.
    Barrett AC; Cook CD; Terner JM; Craft RM; Picker MJ
    Psychopharmacology (Berl); 2001 Nov; 158(2):154-64. PubMed ID: 11702089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic interaction between intrathecal ginsenosides and morphine on formalin-induced nociception in rats.
    Yoon MH; Kim KS; Lee HG; Kim CM; Kim WM; Choi JI; Kim YO
    J Pain; 2011 Jul; 12(7):774-81. PubMed ID: 21459679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized placebo-controlled adjunctive study of an extract of withania somnifera for cognitive dysfunction in bipolar disorder.
    Chengappa KN; Bowie CR; Schlicht PJ; Fleet D; Brar JS; Jindal R
    J Clin Psychiatry; 2013 Nov; 74(11):1076-83. PubMed ID: 24330893
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of endogenous melatoninergic system in development of hyperalgesia and tolerance induced by chronic morphine administration in rats.
    Fan Y; Liang X; Wang R; Song L
    Brain Res Bull; 2017 Oct; 135():105-112. PubMed ID: 28988976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of endothelin in morphine tolerance in neuroblastoma (SH-SY5Y) cells.
    Bhalla S; Ciaccio N; Wang ZJ; Gulati A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1152-6. PubMed ID: 16741067
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional and Morphological Correlates in the Drosophila LRRK2 loss-of-function Model of Parkinson's Disease: Drug Effects of Withania somnifera (Dunal) Administration.
    De Rose F; Marotta R; Poddighe S; Talani G; Catelani T; Setzu MD; Solla P; Marrosu F; Sanna E; Kasture S; Acquas E; Liscia A
    PLoS One; 2016; 11(1):e0146140. PubMed ID: 26727265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance.
    Trang T; Sutak M; Jhamandas K
    Neuroscience; 2007 May; 146(3):1275-88. PubMed ID: 17395382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.